Challenging the validity of a patent through the court systems of Europe and the US can be a time-consuming and expensive process. Jane Wainwright and Daniel Young look at the alternatives.
Post-grant challenge in Europe
European Patent Office (EPO) opposition represents an important part of the toolbox for dealing with competitors’ patents. An opposition can knock out a competitor’s patent for a relatively low cost and can, in many European countries, even lead to a stay of parallel national infringement proceedings. Figures from the EPO also show that approximately two thirds of oppositions result in revocation or amendment of the opposed patent.
Despite the commercial advantages of filing an opposition, they are underused. Th e proportion of oppositions filed against granted patents in any given year is only around 5 percent (4.74 percent in 2011), with more life sciences patents being opposed than other technology areas such as electronics (7 percent for biotechnology compared to 2 percent in each of telecommunications and computer technology).
You need a subscription to continue reading this content.
Start a subscription today to access the LSIPR website.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
News stories up to a week old and feature articles on the day of publication are accessible with a BASIC FREE ACCOUNT.
Register here for free content, or subscribe for access to archive.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’; and for basic access to the latest news on the website and weekly email news alerts choose the 'BASIC FREE ACCOUNT' registration.
Post-grant patents, AIA, inter partes review, patent validity, EPO
